Evidence map›Paper›PMID 36660298›Full record

Review3D printing and additive manufacturing2022

Is COVID-19 the "Catalyst" to Incorporate 3D Printing Technology into the Manufacturing Industry?

Maria Mavri, Vangelis Mennis

Abstract readReview
In one paragraph

Review in 3D printing and additive manufacturing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maria MavriQuantitative Methods Laboratory, Department of Business Administration, University of the Aegean, Chios, Greece.ORCID https://orcid.org/0000-0003-0145-447X
Vangelis MennisQuantitative Methods Laboratory, Department of Business Administration, University of the Aegean, Chios, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The contribution of the fight against COVID-19 to the incorporation of 3D printing technology into the manufacturing industry is the research question of this study. By observing the structure of initiatives of hobbyists and enterprises in the 3D printing industry that are printing health care equipment for nursing staff, we conclude that 3D printing technology could be used for mass production under a different production model. We propose two different typologies of a factory's structure, calling them "Adjust-Semi Cloud Factory 1" and "Semi-Cloud Factory 2." To measure the effectiveness of these new types of factories, we propose a framework based on characteristics and aspects of knowledge management.

Indexed as

3D printingCloud FactoryCOVID-19

Identifiers

PMID36660298
PMCPMC9831562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.